drugset / Trial / NCT00004286
Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy
Phase 3
Completed
120 enrolled
National Center for Research Resources (NCRR)
University of Vermont · collab
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Compare and evaluate the response to treatment with intravenous human immune globulin (IVIG) or placebo in previously untreated patients with chronic inflammatory demyelinating polyneuropathy.
Timeline
- Start
- 1996-02
- Primary completion
- —
- Completion
- 1999-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immune Globulin Intravenous (Human) | Protein / enzyme biologic | — | Intravenous |